NCT04741204 2023-07-06
METBC
Woman's
Phase 4 Withdrawn
Clinical Trials
11 trialsNCT04487912 2021-05-14
Dynamics and Tracer Distribution of Tilmanocept in Early Stage Breast Cancer
University Hospital, Ghent
Phase 4 Withdrawn
NCT02822196 2020-09-16
Serratus Anterior Muscle Plane Block vsThoracic Paravertebral Block For Unilateral Mastectomies
The University of Texas Health Science Center, Houston
Phase 4 Withdrawn
NCT03988114 2019-09-06
proMONARCH
Eli Lilly and Company
Phase 4 Withdrawn
NCT03238703 2018-12-27
Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer
Fred Hutchinson Cancer Center
Phase 4 Withdrawn
NCT02372305 2018-07-18
Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery
University of Arkansas
Phase 4 Withdrawn
NCT03007381 2017-08-16
KANGAROO
Nova Scotia Health Authority
Phase 4 Withdrawn
NCT00774241 2016-11-02
PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast Cancer
Hoffmann-La Roche
Phase 4 Withdrawn
NCT01156961 2016-11-02
A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX)
Hoffmann-La Roche
Phase 4 Withdrawn
NCT01943240 2016-10-27
Pectoral Nerve Blockade in Mastectomy
University of New Mexico
Phase 4 Withdrawn
NCT02637466 2016-09-30
Vortioxetine for MDD, Cognition, and Systemic Inflammatory Biomarkers
University of Miami
Phase 4 Withdrawn